Glaxo Wellcome is already using map data

Ehsan Masood

Nature, 1999, vol. 398, issue 6728, 546-546

Abstract: london The pharmaceutical company Glaxo Wellcome has been actively pursuing ways of incorporating information about variations in gene sequences into its drug discovery programme.

Date: 1999
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/19129 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:398:y:1999:i:6728:d:10.1038_19129

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/19129

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().